Schweingruber, Nils
Bremer, Jan
Wiehe, Anton
Mader, Marius Marc-Daniel
Mayer, Christina
Woo, Marcel Seungsu
Kluge, Stefan
Grensemann, Jörn
Quandt, Fanny
Gempt, Jens
Fischer, Marlene
Thomalla, Götz
Gerloff, Christian
Sauvigny, Jennifer
Czorlich, Patrick http://orcid.org/0000-0003-0865-241X
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 26 November 2023
Accepted: 8 March 2024
First Online: 21 March 2024
Declarations
: We confirm that our manuscript adheres to all the specified instructions and guidelines outlined for authors. The manuscript has been prepared in accordance with the journal’s formatting and stylistic requirements.
: We hereby confirm and attest that this manuscript has not been previously published in any form or medium and is not concurrently under consideration by another scientific journal.
: We hereby confirm that all individuals listed as authors have significantly contributed to the development of this manuscript and satisfy the authorship criteria. Further, we affirm that the final version of the manuscript has been reviewed and approved by all authors.
: The study protocol was reported to the local ethics committee (Ethics committee of the Hamburg Chamber of Physicians, reference number WF-059/20) and was conducted according to the Declaration of Helsinki. Written informed consent was waived because all datasets have been de-identified prior to processing and evaluation for the purposes of the study.
: For the present study, the RECORD (REporting of studies Conducted using Observational Routinely collected Data) checklist was rigorously followed to ensure robust reporting standards. The completed RECORD checklist will be uploaded concomitantly with the manuscript submission.
: The authors declare no competing interests and no conflict of interest. M.F. receives financial support from the External Research Program, Medtronic GmbH, unrelated to this work. C.G. reports personal fees from Amgen, personal fees from Boehringer Ingelheim, personal fees from Daiichi Sankyo, personal fees from Abbott, personal fees from Prediction Biosciences, personal fees from Novartis, and personal fees from Bayer outside the submitted work. G.T. reports personal fees from Acandis, Alexion, Astra Zeneca, Bayer, Boehringer Ingelheim, BristolMyersSquibb, Pfizer, Amarin, Daiichi Sankyo, Stryker, Portola outside the submitted work. J.Gr. received financial study support from Infectopharm and Pfizer, and consultant and lecture fees from Drägerwerk, General Electric Healthcare, and Infectopharm outside of the submitted work.